Common Variable Immunodeficiency is a condition where the body's immune system doesn't work properly. This means it can't fight off infections well, leading to frequent infections.
Every report comes from a Lived member, sent anonymously.
Have you tried IVIG for Common Variable Immunodeficiency?
Common variable immunodeficiency (CVID) is a lifelong immune disorder in which the body does not make enough working antibodies. Antibodies, also called immunoglobulins, are proteins that recognize germs and mark them for destruction. Without enough of them, people with CVID get infections more often, and those infections tend to last longer, come back, or become serious. The sinuses, ears and lungs are affected most, and repeated bouts of bronchitis, sinusitis and pneumonia are the usual reason the condition comes to light. CVID is not only about infections. Many people also develop problems caused by an immune system that is both weak and poorly regulated. These include autoimmune conditions, in which the immune system attacks the body's own tissues (most often blood cells such as platelets), enlarged lymph nodes or spleen, small clusters of immune cells called granulomas, inflammation of the lungs or gut, and a higher risk of lymphoma and stomach cancer. Sometimes one of these problems appears before the infections are recognized. CVID is rare, affecting roughly 1 in 25,000 to 50,000 people, but it is the most common antibody deficiency that causes symptoms in adults. Symptoms can begin at any age, and most people are diagnosed in their twenties or thirties. It is a different condition from the acquired immune deficiency caused by human immunodeficiency virus (HIV) infection.
In most people with CVID, no single cause is found. The core problem is that B cells, the white blood cells that mature into antibody-making plasma cells, fail to develop or work properly, sometimes because they lack the right signals from other immune cells. Researchers think most cases come from a mix of several genes and possibly environmental factors that are not yet understood. A small share of people have a single-gene cause, and these can run in families. Even then, relatives who carry the same gene change may stay healthy, so a family history raises the likelihood without deciding who will be affected. Most people with CVID have no relative with the condition. It is also important to know what CVID is not. Low antibody levels can be caused by other things, including long courses of high-dose steroids, some antiseizure medicines, rituximab (an antibody drug that removes B cells), blood cancers such as chronic lymphocytic leukemia and lymphoma, and conditions that make the body lose protein through the kidneys or gut. These need to be ruled out before CVID is diagnosed, because the treatment and outlook differ.
CVID is often suspected after years of repeated sinus, ear or chest infections, or after a finding such as bronchiectasis (permanently widened, scarred airways), a low platelet count or unexplained granulomas. On average, people wait several years between their first symptoms and a diagnosis, so raising the question matters. The first step is a blood test measuring the main antibody types: IgG, IgA and IgM. Results are compared with the normal range for the person's age, because levels change through childhood. In CVID, IgG is low on at least two tests taken weeks apart, and IgA or IgM is low as well. Most adults with CVID have an IgG level below about 450 mg/dL (4.5 g/L), though some have levels a little higher. Low numbers alone are not enough. A clinician also checks whether the body can make new antibodies, usually by measuring antibody levels to tetanus and pneumococcal (pneumonia) vaccines before and about four weeks after a dose. In CVID, these responses are poor. This testing should happen before antibody treatment starts, although it may be skipped when levels are extremely low and treatment is urgent. Blood tests that count B cells, T cells and other immune cells help separate CVID from other immune disorders, and the evaluation looks for other causes of low antibodies. CVID is usually not diagnosed before age 4, because young children's antibody systems are still maturing. Genetic testing is not needed for everyone but is worth considering when autoimmune, inflammatory or other unusual features are present, since a few single-gene forms have specific treatments.
The main treatment is immunoglobulin replacement therapy: regular doses of antibodies (IgG) collected from the donated plasma of many healthy people. It supplies protection the body cannot make, and it substantially reduces the number and severity of bacterial infections. Treatment is usually lifelong, because the donated antibodies are used up over a few weeks. Immunoglobulin can be given into a vein (intravenous, IVIG), usually every three or four weeks in a clinic or at home, or under the skin (subcutaneous, SCIG), usually weekly or every other week, often self-infused at home. Both work well. IVIG can cause headache, chills, flushing, muscle aches or tiredness during or for a day or two after an infusion, and these are often eased by slowing the infusion or taking a pain reliever such as acetaminophen or an antihistamine beforehand. People who react badly to IVIG often do better with SCIG. The dose is tailored over time based on the trough level (the IgG level just before the next dose) and on whether infections still break through. Other infection care matters too. Infections that do occur are treated promptly with antibiotics, and some people with chronic sinus or lung disease take antibiotics long term. People with bronchiectasis often use daily airway clearance techniques to help clear mucus. Immunoglobulin replacement does not prevent or treat the noninfectious complications of CVID. Autoimmune problems, granulomas, lung inflammation and gut inflammation are treated separately, often with steroids or other medicines that calm the immune system, such as azathioprine or rituximab. Because these drugs further weaken defenses, their use is a balance worked out with specialists. For a small number of people with severe complications, a stem cell transplant may be considered, but it carries a high risk and is rarely used.
With regular immunoglobulin treatment, most people with CVID work, study, exercise and live largely ordinary lives. Infections usually become less frequent and less severe, though they do not disappear entirely. The outlook depends mostly on which form of the condition someone has. People whose CVID causes only infections, and whose lungs have not been badly damaged, can expect a life expectancy close to that of the general population. People who develop chronic lung disease, gut inflammation, autoimmune problems or lymphoma face more health challenges and need more intensive care. Treatment becomes part of the routine. Infusions are scheduled every week or two under the skin, or every few weeks into a vein. Doses may change with weight, pregnancy or new complications, and insurance approval and supply can take ongoing effort. Follow-up with an immunologist is usually at least once a year, more often when problems arise. Visits typically include blood counts, antibody levels and lung function tests. Adults are generally advised to have a detailed chest scan (high-resolution computed tomography, or CT) around diagnosis to look for lung disease, and repeat imaging is guided by symptoms and test results. Swollen lymph nodes are common in CVID and usually not dangerous, but new ones that persist or grow are checked. Vaccines need special handling. Live vaccines contain a weakened germ that can cause illness in people with CVID, so they should not be given. Examples include the measles, mumps and rubella (MMR), chickenpox, yellow fever and oral typhoid vaccines. Most routine vaccines are not needed while on immunoglobulin, but the yearly inactivated flu shot and some other non-live vaccines are often still recommended. Travel plans, especially to places where food- and water-borne infections are common, are worth reviewing with the care team in advance.
Ask about an immune evaluation if you or your child have repeated sinus, ear or chest infections, more than one pneumonia, infections that need many courses of antibiotics, or a diagnosis such as bronchiectasis, immune thrombocytopenia or unexplained granulomas. A close relative with CVID is another reason to ask. If you have CVID, contact your care team promptly about a fever, a new or worsening cough, an infection that is not getting better on treatment, ongoing diarrhea or weight loss, or unusual bruising or bleeding. Swollen lymph nodes that keep growing or do not go away are worth raising with the team within the next few weeks, rather than saving them for a routine visit. Serious bacterial infections such as sepsis and meningitis are more common with CVID and can develop despite treatment. Get emergency care (call 911) for signs of a severe infection: trouble breathing, confusion, a stiff neck with fever, or feeling extremely unwell or faint.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Common Variable Immunodeficiency is like, what's helped you, or ask the community a question.